Clinical presentation and management of stable coronary artery disease: Insights from the international prospective CLARIFY registry - results from the Greek National Cohort

Hellenic Journal of Cardiology

Volumn 55, Issue 6, 2014, Pages 442-447

  Sbarouni, Eftihia ^a   Voudris, Vassilis ^a   Georgiadou, Panagiota ^a   Hamilos, Michalis ^b   Steg, P Gabriel ^c,d,e   Fox, Kim M ^e   Greenlaw, Nicola ^f   Ferrari, Roberto ^g   Vardas, Panos E ^b  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d BICHAT HOSPITAL   (France)

^e ROYAL BROMPTON HOSPITAL   (United Kingdom)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

^g UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

CLARIFY; Presentation; Stable angina; Treatment

Indexed keywords

CARDIOVASCULAR AGENT;

AGE; AGED; ANGIOCARDIOGRAPHY; BODY MASS; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DISEASE MANAGEMENT; EUROPE; FEMALE; GREECE; HEART FUNCTION TEST; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT ACUITY; PREVALENCE; PROCEDURES; REGISTER; RISK FACTOR; SEX DIFFERENCE; SMOKING; STATISTICS AND NUMERICAL DATA;

AGE FACTORS; AGED; BODY MASS INDEX; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DISEASE MANAGEMENT; EUROPE; FEMALE; GREECE; HEART FUNCTION TESTS; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PATIENT ACUITY; PREVALENCE; REGISTRIES; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 84912078335     PISSN: 11099666     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Murray CJ, Lopez AD. Mortality by cause in eight regions of the world: Global Burden of Disease Study. Lancet. 1997; 349: 1269-1276.
2. Anderson GF, Chu E. Expanding priorities--confronting chronic disease in countries with low income. N Engl J Med. 2007; 356: 209-211.
3. Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012; 60: e44-e164.
4. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003; 24: 1601-1610.
5. Steg PG. Heart rate management in coronary artery disease: The CLARIFY registry. Eur Heart J. 2009; 11 (Supplement D): D13-D18.
6. Steg PG, Ferrari R, Ford I, et al; CLARIFY Investigators. Heart rate and use of beta-blockers in stable outpatients with coronary artery disease. PLoS One 2012; 7: e36284.
7. Steg PG, Greenlaw N, Tardif JC, et al. Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. Eur Heart J. 2012; 33: 2831-2840.
8. Ferrari R, Abergel H, Ford I, et al. Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease. Int J Cardiol. 2013; 167: 2938-2943.
9. Daly CA, Clemens F, Sendon JL, et al. The initial management of stable angina in Europe, from the Euro Heart Survey: a description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina. Eur Heart J. 2005; 26: 1011-1022.
10. Boden WE. Surgery, angioplasty, or medical therapy for symptomatic multivessel coronary artery disease: Is there an indisputable “winning strategy” from evidence-based clinical trials? J Am Coll Cardiol. 2004; 43: 1752-1754.
11. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005; 366: 1267-1278.
12. Yusuf S, Pogue J. ACE inhibition in stable coronary artery disease. N Engl J Med. 2005; 352: 937-939.